Glaukos Corporation(NYSE:GKOS) 
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outf...
Website: http://www.glaukos.com
Founded: 1998
Full Time Employees: 600
Sector: Healthcare
Industry: Medical Instruments & Supplies
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 83.39
H 85.47
L 77.91
C 83.65
V 1,715,412
10EMA 83.65
20EMA 83.65
60EMA 83.65
120EMA 83.65
250EMA 83.65